113 related articles for article (PubMed ID: 28108939)
1. Exploration of SAR for novel 2-benzylbenzimidazole analogs as inhibitor of transcription factor NF-κB.
Boggu P; Venkateswararao E; Manickam M; Kim Y; Jung SH
Arch Pharm Res; 2017 Apr; 40(4):469-479. PubMed ID: 28108939
[TBL] [Abstract][Full Text] [Related]
2. Exploration of 2-benzylbenzimidazole scaffold as novel inhibitor of NF-κB.
Boggu P; Venkateswararao E; Manickam M; Kwak D; Kim Y; Jung SH
Bioorg Med Chem; 2016 Apr; 24(8):1872-8. PubMed ID: 26976506
[TBL] [Abstract][Full Text] [Related]
3. Discovery of benzimidazole analogs as a novel interleukin-5 inhibitors.
Boggu PR; Kim Y; Jung SH
Eur J Med Chem; 2019 Nov; 181():111574. PubMed ID: 31400705
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel 3-(hydroxyalkoxy)-2-alkylchromen-4-one analogs as interleukin-5 inhibitors.
Boggu PR; Venkateswararao E; Manickam M; Kim Y; Jung SH
Eur J Med Chem; 2017 Oct; 139():290-304. PubMed ID: 28803045
[TBL] [Abstract][Full Text] [Related]
5. A SAR study on a series of synthetic lipophilic chalcones as inhibitor of transcription factor NF-κB.
Venkateswararao E; Sharma VK; Lee KC; Sharma N; Park SH; Kim Y; Jung SH
Eur J Med Chem; 2012 Aug; 54():379-86. PubMed ID: 22677029
[TBL] [Abstract][Full Text] [Related]
6. New benzimidazoles and their antitumor effects with Aurora A kinase and KSP inhibitory activities.
Abd El-All AS; Magd-El-Din AA; Ragab FA; ElHefnawi M; Abdalla MM; Galal SA; El-Rashedy AA
Arch Pharm (Weinheim); 2015 Jul; 348(7):475-86. PubMed ID: 25900113
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel 2-benzyl-1-indanone analogs as interleukin-5 inhibitors.
Boggu PR; Cho J; Kim Y; Jung SH
Eur J Med Chem; 2018 May; 152():65-75. PubMed ID: 29689475
[TBL] [Abstract][Full Text] [Related]
8. Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors.
Shi L; Wu TT; Wang Z; Xue JY; Xu YG
Eur J Med Chem; 2014 Sep; 84():698-707. PubMed ID: 25064347
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, and molecular docking analysis of novel benzimidazole derivatives as cholinesterase inhibitors.
Yoon YK; Ali MA; Wei AC; Choon TS; Khaw KY; Murugaiyah V; Osman H; Masand VH
Bioorg Chem; 2013 Aug; 49():33-9. PubMed ID: 23886696
[TBL] [Abstract][Full Text] [Related]
10. Novel 2-(2-phenalkyl)-1H-benzo[d]imidazoles as antitubercular agents. Synthesis, biological evaluation and structure-activity relationship.
Gobis K; Foks H; Suchan K; Augustynowicz-Kopeć E; Napiórkowska A; Bojanowski K
Bioorg Med Chem; 2015 May; 23(9):2112-20. PubMed ID: 25797161
[TBL] [Abstract][Full Text] [Related]
11. MAO enzymes inhibitory activity of new benzimidazole derivatives including hydrazone and propargyl side chains.
Can ÖD; Osmaniye D; Demir Özkay Ü; Sağlık BN; Levent S; Ilgın S; Baysal M; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2017 May; 131():92-106. PubMed ID: 28301816
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of radioiodinated benzo[d]imidazole-quinoline derivatives for platelet-derived growth factor receptor β (PDGFRβ) imaging.
Effendi N; Mishiro K; Takarada T; Yamada D; Nishii R; Shiba K; Kinuya S; Odani A; Ogawa K
Bioorg Med Chem; 2019 Jan; 27(2):383-393. PubMed ID: 30563725
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, structure, photoluminescence and antitumour activity of zinc complex based on 2-(2-(1H-benzo-[d]imidazol-2-yl)benzyl)-1H-benzo-[d]imidazole.
Che Z; Wang S; Liu S; Li G; Wu Q; Lin C; Kong L; Wang S
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():878-82. PubMed ID: 25155944
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of benzimidazoles bearing oxadiazole nucleus as anticancer agents.
Rashid M; Husain A; Mishra R
Eur J Med Chem; 2012 Aug; 54():855-66. PubMed ID: 22608854
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of benzimidazole analogs endowed with oxadiazole as selective COX-2 inhibitor.
Rathore A; Rahman MU; Siddiqui AA; Ali A; Shaharyar M
Arch Pharm (Weinheim); 2014 Dec; 347(12):923-35. PubMed ID: 25303727
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiprotozoal activity of novel 2-{[2-(1H-imidazol-1-yl)ethyl]sulfanyl}-1H-benzimidazole derivatives.
Pérez-Villanueva J; Hernández-Campos A; Yépez-Mulia L; Méndez-Cuesta C; Méndez-Lucio O; Hernández-Luis F; Castillo R
Bioorg Med Chem Lett; 2013 Jul; 23(14):4221-4. PubMed ID: 23731944
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of novel benzimidazole derivatives as phosphodiesterase 10A inhibitors with reduced CYP1A2 inhibition.
Hamaguchi W; Masuda N; Isomura M; Miyamoto S; Kikuchi S; Amano Y; Honbou K; Mihara T; Watanabe T
Bioorg Med Chem; 2013 Dec; 21(24):7612-23. PubMed ID: 24238902
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues.
Gobis K; Foks H; Serocki M; Augustynowicz-Kopeć E; Napiórkowska A
Eur J Med Chem; 2015 Jan; 89():13-20. PubMed ID: 25462221
[TBL] [Abstract][Full Text] [Related]
19. Relaxant activity of 2-(substituted phenyl)-1H-benzimidazoles on isolated rat aortic rings: design and synthesis of 5-nitro derivatives.
Estrada-Soto S; Villalobos-Molina R; Aguirre-Crespo F; Vergara-Galicia J; Moreno-Díaz H; Torres-Piedra M; Navarrete-Vázquez G
Life Sci; 2006 Jun; 79(5):430-5. PubMed ID: 16487544
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of 2,3-dihydro- and 5-chloro-2,3-dihydro-naphtho-[1,2-b]furan-2-carboxylic acid N-(substitutedphenyl)amide analogs and their biological activities as inhibitors of NF-κB activity and anticancer agents.
Choi M; Jo H; Kim D; Yun J; Kang JS; Kim Y; Jung JK; Hong JT; Cho J; Kwak JH; Lee H
Arch Pharm Res; 2016 May; 39(5):618-30. PubMed ID: 27021311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
